The crystal structures of three recombinant human hemoglobins, rHb1.0, rHb1.1 and rHb1.2, have been determined in the deoxy state at 1.8 A Ê resolution. Two of the three proteins, rHb1.1 and rHb1.2, contain a genetic fusion of the subunits, a one-or two-glycine link, respectively, whereas rHb1.0 does not. The glycine crosslinks, localized between one N-and C-termini pair of the subunits in the deoxy crystalline state, do not perturb the overall tertiary or quaternary or even the local structure of hemoglobin. Therefore, genetic fusion to prevent the dissociation of the hemoglobin tetramer, thereby inhibiting renal clearance based upon molecular size, is a structurally conservative method to stabilize hemoglobin for use as an oxygen-delivery therapeutic.
Introduction
Several forms of modi®ed hemoglobin are currently being tested as oxygen-delivery therapeutics or`red blood cell substitutes' in clinical applications (Chang, 1998) . Solutions of unmodi®ed hemoglobin are not a potential medical product because the 2 2 tetrameric protein can swiftly dissociate into dimers (Antonini et al., 1968; Ackers et al., 1974) which are cleared rapidly by renal ®ltration Bunn & Jandl, 1969) and may be toxic to the kidney over a longer term (Viele et al., 1997) . Methods to intramolecularly crosslink the hemoglobin tetramer include chemical alteration (Walder et al., 1994) and genetic fusion (Looker et al., 1992) . In addition to delivering oxygen, genetically fused recombinant hemoglobin administered in animal tests maintained kidney function, i.e. no hemoglobin was detected in the urine, papillary damage and glomerular function indicator levels in the urine were normal and histology was also normal, resulting in an increased intravascular half-life (Looker et al., 1992) .
To study the effect of genetic fusion on the structure of hemoglobin, the crystal structures of three recombinant proteins were determined by X-ray analysis. The control is a true 2 2 tetramer; the second two are pseudotetrameric as they contain a`di-' subunit in which both original subunits and the linking residue(s) between them are combined into a single polypeptide chain encoded by one gene. In an attempt to image the introduced crosslinking residues themselves as well as the overall structure, these three hemoglobins were crystallized in their deoxy form under classical`T-state' conditions (Perutz, 1968) , which produces crystals with the entire tetramer in the asymmetric unit.
A naming convention is used for this series of proteins, taking the form rHb#.#. The three letters indicate that the protein is a recombinant hemoglobin, in this series the human sequence, with an initiator methionine replacing the ®rst residue of each subunit chain. The ®rst numeric variable is 1 if the Presbyterian mutation (N108K) is present or 0 if it is absent. This naturally occurring mutation lowers the oxygen af®nity of human hemoglobin by favoring the T allosteric state (Moo-Penn et al., 1978) . The second variable speci®es the number of glycine residues linking the subunits of the hemoglobin tetramer, with a 0 indicating no fusion. The three proteins in this study are labelled rHb1.0, rHb1.1 and rHb1.2, for recombinant hemoglobins containing the Presbyterian mutation and having no, one or two glycines crosslinking the subunits, respectively.
Materials and methods

Crystallization
The recombinant hemoglobins rHb1.0, rHb1.1 and rHb1.2 were crystallized in their deoxy form following a method adapted from Perutz (1968). Each pre-puri®ed oxyhemoglobin was buffer-exchanged using a Sephadex G25 (Pharmacia PD-10) column equilibrated with 10 mM ammonium phosphate pH 7 and then concentrated to 60 g l À1 (4 = 0.8372 l g À1 cm À1 at 540 nm). Batch crystallizations of each hemoglobin were set up in a nitrogen-®lled anaerobic chamber according to Table 1 after deoxygenating all solutions. The 6 Â 50 mm batch tubes were sealed with Para®lm and allowed to stand in the chamber for several weeks. The resulting hemoglobin crystals were mounted in sealed quartz capillary tubes before removal from the oxygen-free atmosphere.
Data collection and reduction
A complete X-ray diffraction data set was collected for each of the three deoxyhemoglobins from one single crystal apiece at room temperature using Cu K radiation from a Siemens rotating-anode generator operated at 50 kV, 90 mA and a Rigaku R-AXIS IIc imaging-plate system. The re¯ections were reduced (see Table 2 ) using the XDS and XSCALE software programs (Kabsch, 1993) . The deoxyhemoglobin crystals were isomorphous to those originally grown by Perutz (1968).
Structure determination and refinement
Each of the three deoxy recombinant human hemoglobin structures was determined using coordinates based on those for deoxy native human hemoglobin (Protein Data Bank entry 2hhb; Fermi et al., 1984) to calculate initial phases. Cycles of conventional positional re®nement were carried out using CNS (Brunger et al., 1998) alternated with manual ®tting by means of the graphics package O (Jones et al., 1991) . Coordinates for the genetic crosslinker, if present, were built into difference electron density obtained from omit maps after simulated annealing (Adams et al., 1997) . Solvent atoms were introduced into density peaks over 4' in a F obs À F calc (and over 2' in a 2F obs À F calc ) electron-density map. A ®nal leastsquares re®nement, conjugate gradient then full matrix, was performed using SHELX (Sheldrick, 1997) . The Fe atoms of the heme prosthetic groups in the deoxy rHb1.2 structure were ®tted anisotropically with SHELX to account for their local difference density. Engh & Huber (1991) topology and parameters were used throughout the re®nement process. All three crystallographic re®nements converged to a ®nal residual under 19% (see Table 3 ).
Results and discussion
Differences between native human hemoglobin and the three recombinant proteins rHb1.0, rHb1.1 and rHb1.2 include (i) the N-terminal valine-to-methionine substitutions for expression in Escherichia coli, (ii) the Presbyterian mutation, a lysine substitution for the native asparagine in the subunits at position 108, and, if present, (iii) the introduced genetic fusion of the two chains in the physiological tetramer, a one-or two-glycine residue crosslink. Despite these differences, each Fermi et al., 1984) and those of the three recombinant hemoglobins in this study are 0.194, 0.228 and 0.206 A Ê for rHb1.0, rHb1.1 and rHb1.2, respectively. The four largest r.m.s. deviations are found in the ®rst two residues of the chains. The genetic fusions that hold the hemoglobin tetramer together clearly do not perturb the overall secondary, tertiary or quaternary structure. The structural role of mutated amino-termini in recombinant hemoglobin has been investigated by Kavanaugh et al. (1992) . Also, the structure of the methionine substitution for N-terminal valine in the genetically crosslinked hemoglobin rHb1.1 (Protein Data Bank entry 1abw) has been examined by Kroeger & Kundrot (1997) . The rHb1.1 structure was redetermined to a higher resolution for the present rHb1.# series to achieve similarity in crystal-growth parameters, instrumentation and re®nement scenarios for comparison purposes. The previous discussions concluded that the valine-tomethionine substitutions do not cause much disruption to the structure of the N-termini regions and that the S atoms of these mutations are involved in stabilizing van der Waals interactions. These mutations in the structures of the current rHb1.# series are not well de®ned by electron density and re®ned to high temperature factors.
The 108 lysine side chain of the Presbyterian mutation present in this rHb1.# series forms a hydrogen bond with that of the native tyrosine at 35 in the deoxy state. This introduced hydrogen bond appears to be stronger in rHb1.0 than in the genetically crosslinked recombinant hemoglobins; the average distance between the N of 108 lysine and the OH of 35 tyrosine is 2.6 A Ê for rHb1.0, 3.4 A Ê for rHb1.1 and 3.6 A Ê for rHb1.2. The Presbyterian mutation contributes to the lowered oxygen af®nity of these recombinant hemoglobins compared with the native protein either by stabilizing the T state with this hydrogen bond (Kroeger & Kundrot, 1997) or by removing the destabilizing native asparagine. A 108 alanine mutation, with no introduced hydrogen bond, also has a lowered oxygen af®nity compared with the native protein (Baxter Hemoglobin Therapeutics, unpublished data).
As the asymmetric unit in this T-state hemoglobin crystal form contains one full 2 2 tetramer or one -Gly n -2 pseudotetramer, the occupancy of the one-or two-glycine link between subunits might be averaged over both sets of noncrystallographic symmetry-related N-and C-termini, i.e. 1 C±N 2 and 2 C±N 1 . This hypothesis was proposed by Looker et al. (1992) based upon their symmetry-averaged deoxy rHb1.1 À deoxy native hemoglobin difference electrondensity map at 2.5 A Ê . Kroeger & Kundrot (1997) claim a unique position for the glycine crosslinker in their 2.0 A Ê structure of rHb1.1 (Protein Data Bank entry 1aby) after 2F obs À F calc and difference Fourier maps, but their coordinate ®le states that the alternate conformation may be present in low (20%) occupancy. The glycine crosslinkers in deoxy rHb1.1 and deoxy rHb1.2 are not occupancy averaged, but localized between one set of N-and C-termini, based upon omit maps after simulated annealing and, more signi®cantly, the rHb1.2 À rHb1.0 and rHb1.1 À rHb1.0 difference maps. The positive difference density in Fig. 1(a) clearly details the main-chain path of the two-glycine crosslink in deoxy rHb1.2; conversely, no difference density exists near the opposite set of rHb1.2 termini (Fig. 1b) . Remarkably, the di-fusion appears between the same set of termini in both deoxy rHb1.1 and rHb1.2. Crystallographic analysis of a three-glycine fusion between subunits in several other deoxy recombinant hemoglobins proved this slightly longer genetic crosslinker to be completely disordered and/or delocalized and the three glycine residues could not be modeled (data not shown).
The introduced genetic fusion of the subunits in rHb1.1 and rHb1.2 does not appreciably disturb local structure (see Fig. 2 ). The orientation of the side chain in Tyr140, the secondto-last residue of the original 1 subunit, is not affected by the glycine crosslink. The same holds true for the second and following residues of the original 2 subunit. The side chain for Arg141, the residue immediately prior to the glycine crosslink, is slightly shifted compared with that for native hemoglobin. The position of the valine immediately following the glycine crosslink in rHb1.1 and rHb1.2, corresponding to the initial residue of the native hemoglobin 2 subunit, is somewhat twisted to accommodate the length of the respective glycine link. Note: the initial residue of the second chain in rHb1.0 (not shown in Fig. 2) is a methionine, not valine, as a consequence of expression in E. coli.
Conclusions
The one-and two-glycine additions employed to genetically fuse the subunits in recombinant human hemoglobin do not disrupt the overall tertiary or quaternary structure. Furthermore, these glycine crosslinks, localized between one N-and Ctermini pair in the deoxy crystalline state, have little impact on their surrounding structure. As a result of genetic fusion, the goal of crosslinking the hemoglobin tetramer to prevent dissociation into dimers subject to swift physiological clearance has been achieved with minimal structural repercussions. This structurally conservative modi®cation allows hemoglobin to be used as an oxygen-delivery therapeutic.
Figure 2
Overlay of HbA 0 , rHb1.1 and rHb1.2. Stereoview includes the subunit N-and Ctermini (glycine crosslink) region; HbA 0 (Protein Data Bank entry 2hhb; Fermi et al., 1984) with associated text is drawn in black, rHb1.1 in light gray and rHb1.2 in dark gray. Coordinates were superposed by overlaying the C atoms of the hemoglobins.
